Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07280039

Mortality and Muscle Mass Loss in Critically Ill Patients.

Mortality and Muscle Mass Loss in Critically Ill Patients: A Prospective, Observational, Multicenter Study.

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
386 (estimated)
Sponsor
Brno University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to monitor changes in muscle mass in critically ill patients and to verify whether a decrease in muscle mass of ≥10% during the first 7 days of hospitalization is associated with increased 28-day mortality. We will be used ultrasoud for measurement the rectus femoris cross sectional area.

Detailed description

All patients will be admitted to participating ICU centers from December 2025 to December 2026 will be screened and enrolled based on the inclusion and exclusion criteria. Informed consent will be requested. Ultrasound measurements will be performed by the same investigator within the first 24h after ICU admssion and again on day 7 of the patient´s ICU stay. All patient data will be entered into case report form by a study physician. In the follow-up will be determined 28 mortality.

Conditions

Timeline

Start date
2025-12-15
Primary completion
2025-12-15
Completion
2026-12-15
First posted
2025-12-12
Last updated
2025-12-12

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT07280039. Inclusion in this directory is not an endorsement.

Mortality and Muscle Mass Loss in Critically Ill Patients. (NCT07280039) · Clinical Trials Directory